the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Oct 24 hearing for Mentega Terbang filmmakers bid to refer constitutional questions

KUALA LUMPUR: The ‘Mentega Terbang’ filmmakers’ application to refer two constitutional questions on the charges of wounding religious feelings under Section 298 of the Penal Code, will be heard on Oct 24 at the High Court here.

Judge K. Muniandy set the date today when the matter came up for mention, in the presence of the deputy public prosecutor Abdul Malik Ayob and lawyer Zaid Malek, representing the director and producer of the movie Mohd Khairianwar Jailani and Tan Meng Kheng.

The two questions are to determine whether or not Section 298 of the Penal Code violates Article 10 (1) (a) of the Federal Constitution, which protects freedom of speech; and whether or not the phrase “wounding the religious feelings of any person”, an element in the offence, violates the rights to a fair trial as the phrase is ambiguous and thus contravenes Articles 5 and 8 of the Constitution.

On June 14, Magistrate Noorelynna Hanim Abd Halim granted leave to the duo to refer constitutional questions to the High Court.

On Jan 17, Khairianwar, 32, who is also a scriptwriter, along with Tan, 36, were charged with offending religious sentiments through the film by allegedly uttering audible words and displaying objects at a location on Jalan Semarak Api at 12.34 pm on Feb 26 last year.

The charges were brought under Section 298 of the Penal Code, which carries a maximum penalty of one year’s imprisonment or a fine, or both, upon conviction.

Previously, the Home Ministry banned the screening and publicising of the film through an order signed by its minister, Datuk Seri Saifuddin Nasution Ismail.

The film, streamed on a video platform, sparked public condemnation and concern for allegedly depicting scenes conflicting with religious beliefs and sentiments.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings